IWWM-10 Session 8: Clinical Trial Updates in WM: Proteasome Inhibitors
The following abstracts represent the presentations given at IWWM-10 (NYC-2018), Session 8: Clinical Trial Updates in WM: Proteasome Inhibitors
Session Chair: Christian Buske (Germany)
Long term follow-up of Bortezomib, Dexamethasone and Rituximab in treatment-naïve WM S. Kastritis (Greece)
Long term follow-up of Carfilzomib, Dexamethasone and Rituximab in treatment-naïve WM K. Meid (USA)
Prospective study of Carfilzomib in previously treated WM patients D. Vesole (USA)
Prospective Study of Ixazomib, Dexamethasone, Rituximab in previously-treated WM patients MJ Kersten (Netherlands)